
Ipca Laboratories Ltd is Rated Hold by MarketsMOJO
2026-11-15 10:10:41Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreIpca Laboratories Gains 0.79%: 3 Key Factors Driving the Week’s Momentum
2026-11-07 14:04:55Key Events This Week 2 Nov: Stock opens at Rs.1,950.00, Sensex gains 1.57% 5 Nov: Q2 FY27 results announced with 33% profit surge; technical momentum shifts bullish 6 Nov: Positive quarterly performance confirmed amid financial trend adjustment 6 Nov: Week closes at Rs.1,942.95, up 0.79% for the week Week OpenRs.1,927.70 We...
Read More
Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-11-05 08:05:12Ipca Laboratories Ltd has demonstrated a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of key technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest strengthening price momentum and a positive outlook for the mid-cap pharmaceutical player.
Read More
Ipca Laboratories Ltd is Rated Buy by MarketsMOJO
2026-11-04 10:11:01Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 18 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 November 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read More
Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-29 08:02:30Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 2.74%, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, providing investors with a comprehensive view of Ipca Labs’ current market positioning and outlook.
Read More
Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-10-27 08:05:29Ipca Laboratories Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bullish stance to a more confident bullish trend. Despite a minor dip of 0.52% on 27 Oct 2026, the stock’s underlying technical indicators suggest strengthening price momentum, supported by mixed but improving signals across weekly and monthly timeframes.
Read MoreIpca Laboratories Gains 6.25%: 3 Key Factors Driving the Weekly Rally
2026-10-24 15:00:05Key Events This Week 19 Oct: Technical momentum shifts amid mixed market signals 21 Oct: Intraday high reached with 5.87% surge 22 Oct: Minor pullback amid sector weakness 23 Oct: Strong close at Rs.1,951.25 (+2.55%) Week OpenRs.1,836.50 Week CloseRs.1,951.25<div class="stat-change positi...
Read More
Ipca Laboratories Ltd is Rated Buy
2026-10-24 10:10:14Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 18 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read More
Ipca Laboratories Ltd Surges 5.87% to Day's High of Rs 1921.7 — Outperforms Sector by 6.88 Percentage Points
2026-10-21 15:22:14The Sensex declined by 0.46% on 21 Oct 2026, while Ipca Laboratories Ltd surged 5.87%, outperforming its Pharmaceuticals & Biotechnology sector by 6.88 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.
Read MoreCLOSING OF MANUFACTURING OPERATION AND SALE OF LEASEHOLD LAND AND OLD FACTORY BUILDINGS / STRUCTURES / SHEDS STANDING THEREON AT COMPANYS DRUG INTERMEDIATES / BULK DURGS MANUFACTURING UNIT SITUATED AT MIDC MAHAD
20-Nov-2026 | Source : BSEClosing of manufacturing operations and sale of leasehold land and old factory building / structures / sheds standing thereon at Companys Drug Intermediates / bulk drug manufacturing unit situated at MIDC Mahad
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
06-Nov-2026 | Source : BSETranscript of Conference Call held on 05.11.2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSECopy of Newspaper Publication
Corporate Actions
No Upcoming Board Meetings
Ipca Laboratories Ltd has declared 600% dividend, ex-date: 07 Aug 26
Ipca Laboratories Ltd has announced 1:2 stock split, ex-date: 10 Jan 22
No Bonus history available
No Rights history available